Not applicableStudy completedNCT06408051
What this trial is testing
Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
Who this might be right for
Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
Hisar Intercontinental Hospital 60